Japan vs Switzerland: Proportion of the target population who received a 3rd dose of
Japan
91.0%
in 2024
Switzerland
91.0%
in 2024
Japan rank
55th
Switzerland rank
55th
Proportion of the target population who received a 3rd dose of over time
- Japan
- Switzerland
How they compare
Japan currently reports 91.0% against 91.0% in Switzerland, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Japan ahead.
Japan ranks 55th and Switzerland ranks 55th of 157 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.9% | 75.4% | 22.4% | Japan |
| 2020s | 95.2% | 88.6% | 6.6% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Japan or Switzerland?
- Japan, at 91.0% against 91.0% in Switzerland as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Japan and Switzerland?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Switzerland?
- 14 years are reported by both, from 2011 to 2024.
- How do Japan and Switzerland rank globally for proportion of the target population who received a 3rd dose of?
- Japan ranks 55th and Switzerland ranks 55th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.